News & Updates
Showing Multidisciplinary articles
Showing
Rituximab-temozolomide-radiation combo shows promise in recurrent primary CNS lymphoma
Use of rituximab, temozolomide, and radiation appears safe and effective as salvage therapy for patients with recurrent or refractory primary central nervous system (CNS) lymphoma, according to a study in the Philippines, the results of which were presented at the recent AAN 2023.
Toripalimab plus bevacizumab, SoC demonstrates promising efficacy for cervical cancer
Preliminary results of a single-arm, open-label, phase II trial demonstrated the efficacy of a combination regimen comprising toripalimab, bevacizumab, and platinum-based chemotherapy for women with refractory, recurrent, or metastatic cervical cancer.
Vigorous hydration prevents post-ERCP pancreatitis
Vigorous periprocedural hydration (vHR) appears to be as effective as postprocedure per-rectal indomethacin for the prevention of postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), a study has shown.
Weight gain persists, obesity rises in children after pandemic lockdown
Some children, particularly boys, continue to gain weight even after COVID-19 pandemic lockdown measures have been eased, indicating the challenges in reversing the effects of lockdowns, reveals a study in Argentina. However, sedentary behaviours have decreased while quality of life has improved.